Skip to main content

Jobs Job Match Companies People Locations Salaries Blog Resume Scanner Post a Job

Zero G Talent

Jobs
Job Match
Companies
People
Locations
Salaries
Blog
Resume Scanner
Post a Job

About
Contact
Privacy
Terms

© 2026 Zero G Talent. All rights reserved.

Home
People
David Reynolds

David Reynolds

David Reynolds

CEO and Co-Founder, LOQUS23 THERAPEUTICS

Venture Partner at Dementia Discovery Fund

About

Male

David Reynolds is a CEO at LoQus23 Therapeutics Ltd. He Attended University of Cambridge.

Experience

Dementia Discovery Fund

Venture Partner · 2019 – present

Grant76London, England, United KingdomBiotechnology · Life Science

CEO and Co-Founder · LOQUS23 THERAPEUTICS

Education

University of Cambridge

People at Dementia Discovery Fund

Venture Partner

Damian Crowther

Entrepreneur In Residence

Data from: crunchbase

Investment Associate

Investment Associate

View all at Dementia Discovery Fund →

Latest from David Reynolds

Headlines from Google News. Social posts load from the platform only when you open a tab.

LoQus23 says drug candidate can boost fight against Huntington's Disease
Business Weekly · Jan 6
Rare diseases, big advances: how research is powering a new era of treatments
Drug Target Review · Feb 28
LoQus23 Therapeutics: £35 Million (Series A) Secured To Advance Small Molecule Somatic Expansion Inhibition Therapy
pulse2.com · Oct 4
LoQus23 Therapeutics secures £35 million in series A funding
The Pharma Letter · Oct 2
LoQus23 Therapeutics Raises £35M in Series A financing
finsmes.com · Oct 2